Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation

Future Med Chem. 2021 Mar;13(6):543-549. doi: 10.4155/fmc-2020-0297. Epub 2021 Feb 4.

Abstract

Aim: In the present study, the inhibitory potential of rutin-loaded liquid crystalline nanoparticles (LCNs) on oxidative stress was determined in human bronchial epithelial cells (BEAS-2B) by analysing the expression levels of different antioxidant (NADPH quinine oxidoreductase-1 (NQO1); γ-glutamyl cysteine synthetase catalytic subunit (GCLC)) and pro-oxidant (NADPH oxidase (Nox)-4; Nox2B) genes. Results: Our findings revealed that the rutin-loaded LCNs inhibited the genes, namely Nox2B and Nox4, which caused oxidative stress. In addition, these nanoparticles demonstrated an upregulation in the expression of the antioxidant genes Gclc and Nqo-1 in a dose-dependent manner. Conclusion: The study indicates the promising potential of rutin-loaded LCNs as an effective treatment strategy in patients with high oxidant loads in various respiratory diseases.

Keywords: antioxidant; inflammation; lipopolysaccharide; oxidative stress genes; rutin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchi / cytology
  • Cell Line
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Humans
  • Lipopolysaccharides / pharmacology
  • Liquid Crystals / chemistry*
  • NAD(P)H Dehydrogenase (Quinone) / genetics
  • NAD(P)H Dehydrogenase (Quinone) / metabolism
  • NADPH Oxidase 2 / genetics
  • NADPH Oxidase 2 / metabolism
  • Nanoparticles / chemistry*
  • Oxidative Stress / drug effects*
  • Polymerase Chain Reaction
  • Rutin / chemistry
  • Rutin / pharmacology*
  • Up-Regulation / drug effects

Substances

  • Lipopolysaccharides
  • Rutin
  • NADPH Oxidase 2
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human